PEOPLE - Johnson & Johnson (US) makes appointment:
This article was originally published in Clinica
Executive Summary
Johnson & Johnson (New Brunswick, New Jersey) has appointed David Satcher to the board. Dr Satcher, who formerly served as the 16th surgeon general of the US, currently serves as senior visiting fellow at the Kaiser Family Foundation, Washington, DC.
You may also be interested in...
Can Synthetic CBD Overcome Cannabis Stigma And Break EU Novel Foods Deadlock?
Regulatory Blessings Helping China CAR-Ts March Closer To Global Cancer Patients?
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.
Polpharma Pursues Tysabri Through Antelope Trial
The first of around 260 patients for a clinical trial comparing its PB006 natalizumab biosimilar candidate to Biogen’s Tysabri reference brand have been recruited by Polpharma Biologics, which has just added Karsten Roth and Alexandra Moulson to its team.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: